GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc. is associated with Capstar Special Purpose Acquisition Corp, which traded under the ticker CPSR and completed its IPO in 2020. The SPAC was sponsored by Capstar Special Purpose Acquisition Holdings LLC and targeted the healthcare sector, ultimately pursuing a business combination with Gelesis, an Italy-founded biotech company developing superabsorbent hydrogel-based treatments for weight management, including its FDA-cleared product Plenity. The 8-K filing dated July 19, 2021 relates to activity surrounding the proposed merger transaction, which later closed and resulted in Gelesis listing on the New York Stock Exchange. Sign up at SpacDesk for complete filing history, deal timelines, and sponsor intelligence on CPSR and hundreds of other SPACs.